Diagonal Therapeutics
Latest round
- Series B
Last raised
- Jan 2026
Total raised
- $150M
Investors
- 19
About Diagonal Therapeutics
Based in Massachusetts, US, and founded in 2022, Diagonal Therapeutics, Inc. develops agonist antibodies by combining patented computational and experimental methods. In January 2026, Diagonal Therapeutics, Inc. Diagonal Therapeutics' proprietary platform, Diagonal's, utilizes a combination of computational and experimental techniques to identify agonist antibodies. The platform enables the generation of deep immune repertoires and the development of multispecific antibodies, allowing for the exploration of over 10 billion possible combinations. The company's pipeline includes promising candidates targeting a range of diseases, including hereditary hemorrhagic telangiectasia (HHT), pulmonary arterial hypertension (PAH), and solid tumors.
Who invested in Diagonal Therapeutics
19 investors across 3 rounds
See all investors in Diagonal Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Diagonal Therapeutics
Who invested in Diagonal Therapeutics?
Diagonal Therapeutics has 19 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Diagonal Therapeutics raised?
Diagonal Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Diagonal Therapeutics last raise money?
Diagonal Therapeutics's most recent round on record is a Series B, in Jan 2026.
What does Diagonal Therapeutics do?
Based in Massachusetts, US, and founded in 2022, Diagonal Therapeutics, Inc.
Where is Diagonal Therapeutics headquartered?
Diagonal Therapeutics is headquartered in Watertown, US.
Which VCs invest in companies like Diagonal Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Diagonal Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Diagonal Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.